Skip to content

Integrating Probiotics into a One-Day Diabetes Clinic: Outcomes in Gestational Diabetes

Integrating Probiotics into a One-Day Diabetes Clinic: Outcomes in Gestational Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100649
Enrollment
Unknown
Registered
2025-04-11
Start date
2023-01-13
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes mellitus

Interventions

Study Group:the one-day clinic diabetes mellitus management model with probiotics
Control Group:the one-day clinic diabetes mellitus management model

Sponsors

The Fourth Hospital of Shijiazhuang
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for GDM: At 24–28 weeks of gestation, an oral glucose tolerance test (OGTT) with 75 g anhydrous glucose is performed. A diagnosis of gestational diabetes mellitus (GDM) can be made if any one of the following criteria is met: (1) fasting blood glucose >= 5.1 mmol/L;(2) 1-hour blood glucose >= 10.0 mmol/L, or (3) 2-hour blood glucose >= 8.5 mmol/L; 2. Age between 20 and 40 years; 3. Singleton pregnancy conceived naturally.

Exclusion criteria

Exclusion criteria: 1.Meet the diagnostic criteria for pre-existing diabetes in pregnancy: According to the guidelines published by the American Diabetes Association (ADA) in 2011, if a woman has a fasting plasma glucose (FPG) >= 7.0 mmol/L or glycated hemoglobin (HbA1c) >= 6.5% or random blood glucose >= 11.1 mmol/L with symptoms during the initial prenatal examination, she is diagnosed with pre-existing diabetes in pregnancy; 2. Presence of other pregnancy complications before participating in the study; 3. History of diabetes, hyperlipidemia, hypertension, or other related diseases before pregnancy; 4. Incomplete data or refusal to participate in the study, or inability to cooperate with blood sampling.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose;2-hour postprandial blood glucose;fasting insulin ;Glycosylated hemoglobin;Blood lipids;CRP;

Secondary

MeasureTime frame
Body weight;

Countries

China

Contacts

Public ContactWang Wei

The Fourth Hospital of Shijiazhuang

349678783@qq.com+86 159 3399 6580

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 28, 2026